A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatment

By Popovic‐Todorovic B.  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2275-2282

Oxford University Press

Access to resources Recommend Favorite

Infertility. A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI

By Wikland M.  

Human Reproduction, Vol. 16, Iss. 8, 2001-08 ,pp. : 1676-1681

Oxford University Press

Access to resources Recommend Favorite

IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression

By Bjercke S.   Fedorcsak P.   Åbyholm T.   Storeng R.   Ertzeid G.   Oldereid N.   Omland A.   Tanbo T.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2441-2447

Oxford University Press

Access to resources Recommend Favorite

A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

By Kilani Z.  

Human Reproduction, Vol. 18, Iss. 6, 2003-06 ,pp. : 1194-1199

Oxford University Press

Access to resources Recommend Favorite

Meta‐analysis of recombinant FSH and urinary‐derived gonadotrophins for IVF or ICSI

By Al‐Inany Hesham  

Human Reproduction, Vol. 18, Iss. 7, 2003-07 ,pp. : 1555-1556

Oxford University Press

Access to resources Recommend Favorite